Risk of mortality associated with antipsychotic and other neuropsychiatric drugs in pneumonia patients

被引:35
|
作者
Barnett, MJ
Perry, PJ
Alexander, B
Kaboli, PJ
机构
[1] Iowa Citiy Vet Adm Hosp, Ctr Res Implementat Innovat Strategies Practice, Iowa City, IA 52246 USA
[2] Univ Iowa, Coll Pharm, Iowa City, IA 52242 USA
[3] Univ Iowa, Carver Coll Med, Dept Internal Med, Iowa City, IA 52242 USA
关键词
D O I
10.1097/01.jcp.0000203598.43314.34
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Objective: To evaluate the use of typical and atypical antipsychotic medications and associated in-hospital mortality in a group of Veterans Administration (VA) patients with pneumonia. Method: Our cohort consisted of 14,057 VA patients admitted for pneumonia in fiscal year (FY) 2003. Exposure to typical and atypical antipsychotics and other neuropsychiatric drugs was based on a prescription within 120 days preceding admission. Multivariate models determined the odds of mortality associated with each drug class and risk adjusted for comorbidity, admission source, demographic factors, and concurrent mental health conditions. The referent group for each analysis was pneumonia patients not receiving neuropsychiatric drugs. Results: In adjusted analyses, the odds of in-hospital mortality for VA patients admitted with pneumonia was higher for recent exposure to typical antipsychotics (OR = 1.5 1, 95% CI = 1.042.19; P = 0.03) when compared to patients not receiving neuropsychiatric medications. Patients exposed to atypical antipsychotics (OR = 1.20, 95% CI = 0.96-1.50, P =.10), tri-cyclic antidepressants (OR=1.20, 95% CI = 0.44-1.55; P = 0.15), other antidepressants (OR = 1.07 95% CI 0.93- 1.23; P = 0.37) or mood stabilizers (OR=0.91, 95% CI= 0.73-1.14; P= 0.41) had no significant difference in in-hospital mortality. Conclusion: In spite of recent safety concerns for atypical antipsychotics, we found no increased risk of mortality in acutely ill pneumonia patients. Rather, we found a higher adjusted mortality rate for patients taking typical antipsychotics. The contrasting mortality risks for patients taking typical and atypical antipsychotics may represent unmeasured severity of illness or comorbidity. Regardless, any antipsychotics should be used with caution and the efficacy and safety of alternative agents should be considered.
引用
收藏
页码:182 / 187
页数:6
相关论文
共 50 条
  • [2] Antipsychotic use in elderly patients and the risk of pneumonia
    Gambassi, Giovanni
    Sultana, Janet
    Trifiro, Gianluca
    EXPERT OPINION ON DRUG SAFETY, 2015, 14 (01) : 1 - 6
  • [3] Treatment of neuropsychiatric symptoms in dementia with antipsychotic drugs
    Gertz, H. J.
    NERVENHEILKUNDE, 2013, 32 (10) : 751 - 754
  • [4] Use of antipsychotic drugs was associated with increased risk for hyperglycemia in older patients with diabetes
    Ng, Bradley
    ANNALS OF INTERNAL MEDICINE, 2009, 151 (10)
  • [5] Risk factors related to mortality in patients with ventilator associated pneumonia.
    Attie, Shiry
    Bonelli, Ignacio
    Mazzuoccolo, Luis
    Stryjewski, Martin
    Valentini, Ricardo
    CRITICAL CARE MEDICINE, 2006, 34 (12) : A92 - A92
  • [6] Risk factors associated with mortality from pneumonia among patients with pneumoconiosis
    Jo, Bum Seak
    Lee, Jongin
    Cho, YounMo
    Byun, Junsu
    Kim, Hyoung Ryoul
    Koo, Jung Wan
    Myong, Jun Pyo
    ANNALS OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE, 2016, 28
  • [7] RISK FACTORS ASSOCIATED WITH MORTALITY FROM PNEUMONIA AMONG PATIENTS WITH PNEUMOCONIOSIS
    Myong, J. P.
    Bum-Seak, J.
    RESPIROLOGY, 2016, 21 : 142 - 142
  • [8] Cumulative dosages of antipsychotic drugs are associated with increased mortality rate in patients with Alzheimer's dementia
    Nielsen, R. E.
    Lolk, A.
    Valentin, J. B.
    Andersen, K.
    ACTA PSYCHIATRICA SCANDINAVICA, 2016, 134 (04) : 314 - 320
  • [9] Effect of antipsychotic drugs on mortality risk among dementia patients with and without comorbidity: a nationwide study
    Norgaard, A.
    Jensen-Dahm, C.
    Wimberley, T.
    Svendsen, J. H.
    Ishtiak-Ahmed, K.
    Munk-Laursen, T.
    Waldemar, G.
    Gasse, C.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 18 - 18
  • [10] Mortality risk factors in ventilator associated pneumonia
    Iribarren B, Osvaldo
    Aranda T, Jacquelin
    Dorn H, Lilian
    Ferrada M, Monica
    Ugarte E, Hector
    Koscina M, Vinka
    Lopez R, Daniel
    Morel F, Mauro
    REVISTA CHILENA DE INFECTOLOGIA, 2009, 26 (03): : 227 - 232